Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

NCT00049699

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Yale Comprehensive Cancer Center New Haven, Connecticut, United States

Veterans Affairs Medical Center - West Haven West Haven, Connecticut, United States

Ireland Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

NCT00562380

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +57 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Rituximab in Treating Patients With Multiple Myeloma

NCT00003554

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib

NCT01060202

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies

NCT00697671

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +28 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL

NCT01896752

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Department of Pediatrics, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00089154

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: Chronic Lymphocytic Leukemia Research Consortium (CRC) La Jolla, California, United States

Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)

NCT01402687

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

NCT00006013

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00062296

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions